Intra-Articular Application of Autologous, Fat-Derived Orthobiologics in the Treatment of Knee Osteoarthritis: A Systematic Review
- PMID: 38727286
- PMCID: PMC11083621
- DOI: 10.3390/cells13090750
Intra-Articular Application of Autologous, Fat-Derived Orthobiologics in the Treatment of Knee Osteoarthritis: A Systematic Review
Abstract
The aim of this study was to review the current literature regarding the effects of intra-articularly applied, fat-derived orthobiologics (FDO) in the treatment of primary knee osteoarthritis over a mid-term follow-up period. A systematic literature search was conducted on the online databases of Scopus, PubMed, Ovid MEDLINE, and Cochrane Library. Studies investigating intra-articularly applied FDO with a minimum number of 10 knee osteoarthritis patients, a follow-up period of at least 2 years, and at least 1 reported functional parameter (pain level or Patient-Reported Outcome Measures) were included. Exclusion criteria encompassed focal chondral defects and techniques including additional arthroscopic bone marrow stimulation. In 28 of 29 studies, FDO showed a subjective improvement in symptoms (pain and Patient-Reported Outcome Measures) up to a maximum follow-up of 7.2 years. Radiographic cartilage regeneration up to 3 years postoperatively, as well as macroscopic cartilage regeneration investigated via second-look arthroscopy, may corroborate the favorable clinical findings in patients with knee osteoarthritis. The methodological heterogeneity in FDO treatments leads to variations in cell composition and represents a limitation in the current state of knowledge. However, this systematic review suggests that FDO injection leads to beneficial mid-term results including symptom reduction and preservation of the affected joint in knee osteoarthritis patients.
Keywords: adipose tissue-derived stromal cells; cartilage regeneration; knee osteoarthritis; mesenchymal stem cells; orthobiologics; stromal vascular fraction.
Conflict of interest statement
The authors declare no conflicts of interest. Liparthroplasty and Supercharged Liparthroplasty are Trademarks owned by Dominik Duscher.
Figures
Similar articles
-
Should I add orthobiologics to my knee osteotomy practice? A systematic review.J ISAKOS. 2024 Dec;9(6):100282. doi: 10.1016/j.jisako.2024.06.001. Epub 2024 Jun 6. J ISAKOS. 2024. PMID: 38851324 Review.
-
Intra-articular Mesenchymal Stem Cells in Osteoarthritis of the Knee: A Systematic Review of Clinical Outcomes and Evidence of Cartilage Repair.Arthroscopy. 2019 Jan;35(1):277-288.e2. doi: 10.1016/j.arthro.2018.07.028. Epub 2018 Nov 16. Arthroscopy. 2019. PMID: 30455086
-
Autologous microfragmented adipose tissue treatment of knee osteoarthritis demonstrates effectiveness in 68% of patients at 4-year follow-up.Arch Orthop Trauma Surg. 2024 Sep;144(9):3925-3935. doi: 10.1007/s00402-023-05143-y. Epub 2024 Jan 11. Arch Orthop Trauma Surg. 2024. PMID: 38212589 Free PMC article.
-
Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.J Vis Exp. 2023 May 26;(195). doi: 10.3791/6561. J Vis Exp. 2023. PMID: 37235796
-
Exercise for osteoarthritis of the knee.Cochrane Database Syst Rev. 2015 Jan 9;1(1):CD004376. doi: 10.1002/14651858.CD004376.pub3. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2024 Dec 3;12:CD004376. doi: 10.1002/14651858.CD004376.pub4. PMID: 25569281 Free PMC article. Updated. Review.
Cited by
-
Understanding and controlling the variables for stromal vascular fraction therapy.World J Stem Cells. 2024 Aug 26;16(8):784-798. doi: 10.4252/wjsc.v16.i8.784. World J Stem Cells. 2024. PMID: 39219728 Free PMC article. Review.
-
Association of autoimmune diseases with the occurrence of osteoarthritis: a gene expression and Mendelian randomization study.Front Med (Lausanne). 2024 Sep 5;11:1435312. doi: 10.3389/fmed.2024.1435312. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39301493 Free PMC article.
References
-
- Vogelmann T., Roessler P.P., Buhs M., Ostermeier S., Gille J., Hoburg A., Zöllner Y., Schwarz S., Schubert T., Grebe M., et al. Long-term cost-effectiveness of matrix-associated chondrocyte implantation in the German health care system: A discrete event simulation. Arch. Orthop. Trauma Surg. 2023;143:1417–1427. doi: 10.1007/s00402-021-04318-9. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources